Integrated Scientific Advice: Early Multi-Stakeholder Engagement in Product Development to Improve Patient Access in the US and EU

16th October, 2017
Time: 08:30 - 18:00

Location: Grapevine, Texas
Timezone: (GMT -5:00) Eastern Time (US & Canada), Bogota, Lima


Dr. Matthew Bending
Mr. Rory Graham
Manasee Shah
Dr. Fanta Waterman
Mr. Dave Clark
Mr. Michael Pace
Dr. Jonathan Watanabe

On Monday, October 16, ICON and Mapi led a workshop to discuss the value and importance of obtaining multi-stakeholder advice early in the clinical development programme.

The workshop, titled “Early Multi-Stakeholder Engagement in Product Development: Improving Patient Access in the US and EU”, included various perspectives regarding the importance of early engagement, including speakers providing an academic, regulatory, HTA and US payer decision-maker and industry perspective.

Complete the form to receive a detailed summary of the workshop.